AUTL
Autolus Therapeutics
AUTL
AUTL
84 hedge funds and large institutions have $184M invested in Autolus Therapeutics in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 30 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
27% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 30
33% less capital invested
Capital invested by funds: $277M → $184M (-$92.7M)
Holders
84
Holding in Top 10
3
Calls
$643K
Puts
–
Top Buyers
| 1 | +$5.49M | |
| 2 | +$1.48M | |
| 3 | +$825K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$651K |
| 5 |
Millennium Management
New York
|
+$311K |
Top Sellers
| 1 | -$3.35M | |
| 2 | -$2.7M | |
| 3 | -$2.58M | |
| 4 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
-$2.33M |
| 5 |
Renaissance Technologies
New York
|
-$1.22M |
